Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
ResMed Inc is preparing for a significant sale of 6,160 common shares on the NYSE, with an estimated market value of around $1.5 million. The sale, scheduled for November 22, 2024, involves shares acquired through restricted stock vesting and stock option exercises. This move signals potential opportunities for investors interested in ResMed’s market performance.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.
